Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × HCC × Tirapazamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 3 Head and Neck Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Neuroendocrine Tumors 1 Laryngeal Diseases 1 Hypoxia 1 HCC 1 Carcinoma, Squamous Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06844357 2025-04-06

A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.

Zhejiang Raygene Pharmaceuticals Co., Ltd

Phase 2/3 Recruiting

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡